TLIS

Talis Biomedical Corp

TLIS, USA

Talis Biomedical Corporation does not have significant operations. Previously, it was involved in the development of medical devices for infectious diseases and other conditions at the point of care in the United States. The company evaluates strategic alternatives, including acquisition, merger, reverse merger, divestiture of assets, a voluntary reorganization, dissolution or liquidation, and licensing or other strategic transactions. Talis Biomedical Corporation was incorporated in 2013 and is based in Chicago, Illinois.

https://talisbio.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
TLIS
stock
TLIS

Stock market holidays 2026: NSE releases full list, stock market to remain shut for 15 days — check details MSN

Read more →
TLIS
stock
TLIS

Stock market holidays 2026: NSE releases full list, stock market to remain shut for 15 days — check details livemint.com

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2024-06-30)

Rating:

STRONG SELL

Target Price:

$5

Analyst Picks

Strong Buy

0

Buy

0

Hold

0

Sell

0

Strong Sell

1

Finn Analysis

(Last Updated 2024-06-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

0.06

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-18.20 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-12.17 %

Low ≤ 2%

High ≥ 10%

Debt to Equity

-

High

0.50

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 16.22% of the total shares of Talis Biomedical Corp

1.

BML Capital Management LLC

(13.6438%)

since

2024/09/30

2.

Springbok Capital Management, LLC

(0.819%)

since

2024/06/30

3.

Geode Capital Management, LLC

(0.7691%)

since

2024/06/30

4.

Susquehanna International Group, LLP

(0.6368%)

since

2024/06/30

5.

BlackRock Inc

(0.2343%)

since

2024/06/30

6.

Tower Research Capital LLC

(0.0481%)

since

2024/06/30

7.

BlackRock Event Driven Equity Instl

(0.0308%)

since

2024/09/30

8.

Morgan Stanley - Brokerage Accounts

(0.0095%)

since

2024/06/30

9.

SSgA U.S. Total Market Index Strategy

(0.0092%)

since

2024/06/30

10.

Steward Partners Investment Advisory, LLC

(0.0081%)

since

2024/06/30

11.

Advisor Group Holdings, Inc.

(0.0046%)

since

2024/06/30

12.

Larson Financial Group, LLC

(0.0008%)

since

2024/06/30

13.

Bank of America Corp

(0.0007%)

since

2024/06/30

14.

UBS Group AG

(0.0006%)

since

2024/06/30

15.

Guggenheim Active Allocation Fund

(0.0003%)

since

2024/08/31

16.

JPMorgan Chase & Co

(0.0002%)

since

2024/06/30

17.

Qube Research & Technologies

(0.0001%)

since

2024/06/30

18.

ADAR1 Capital Management LLC

(0%)

since

2024/06/30

19.

Wells Fargo & Co

(0%)

since

2024/06/30

20.

Baker Bros Advisors LP

(0%)

since

2024/09/30

21.

Renaissance Technologies Corp

(0%)

since

2024/09/30

22.

Vanguard Group Inc

(0%)

since

2024/09/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2024-06-30

EPS Actual

-4.8556

EPS Estimate

-5.91

EPS Difference

1.0544

Surprise Percent

17.8409%

Investing Fit Scorecard

(Last Updated 2024-06-30)

Deep Value
Strong Deep Value(6.5)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(4.8)
GARP
Not Attractive for GARP(2.5)
Growth
Weak Growth Prospect(1)
Momentum
Moderate Momentum(3.5)
Net Net
Strong Net-Net(8)
Quality
Low Quality Business(2.5)
Value
Fair Value(5)

Income Statement

(Last Updated 2024-06-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2024-06-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2024-06-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.